Early evidence from a next generation coronary sinus reducer for the treatment of coronary microvascular dysfunction
Sponsored by Vahaticor
Other coronary interventions
Symposium
Complications
VahatiCor
Room 241
Watch this session if you want
- To understand practical aspects of the implantation of a next generation self-expanding nitinol coronary sinus reducer
- To learn about the clinical evidence from VahatiCor’s early feasibility SERRA I study for treating coronary microvascular dysfunction
- To start assessing coronary microvascular function with coronary functional testing in your lab
